Jan Oosting

4.1k citations

73 papers · 2.5k indexed · h-index 32

Impact in

Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Oncology top 5%
- Cancer Cells and Metastasis

Papers in

Cancer Research 21
- Cancer Genomics and Diagnostics 8
- Cancer-related molecular mechanisms research 8
Pathology and Forensic Medicine 19
- Genetic factors in colorectal cancer 18

Co-authors: Tom van Wezel Ronald van Eijk Harry A.J. Struijker-Boudier Paul H.C. Eilers Hans Morreau Ben Janssen Cees J. Cornelisse Rob A.�E.�M. Tollenaar
Journals: The Journal of Pathology (7 papers)BMC Cancer (5 papers)Oncotarget (3 papers)Genes Chromosomes and Cancer (3 papers)PLoS ONE (3 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Jan Oosting

71 papers receiving 2.5k citations

Peers

Countries citing papers authored by Jan Oosting

Since Specialization

Citations

This map shows the geographic impact of Jan Oosting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Oosting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Oosting more than expected).

Fields of papers citing papers by Jan Oosting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Oosting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Oosting. The network helps show where Jan Oosting may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jan Oosting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Oosting Line = papers co-authored together Jan Oosting links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic Cancer Cancers ·Thomas P. Brouwer, Marieke E. Ijsselsteijn, Jan Oosting, Dina Ruano, Manon van der Ploeg, Frederike Dijk, Bert A. Bonsing, Arantza Fariña Sarasqueta, Hans Morreau, Alexander L. Vahrmeijer, Noel F.C.C. de Miranda	2022	18
2	Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma British journal of surgery ·Shaoshuai Ding, Yuichi Saito, Takaki Yoshikawa, Takashi Oshima, Jeremy D. Hayden, Jan Oosting, F Hostalka, Lindsay C. Hewitt, Floor van Lieshout, Alexander Wright, ชัยชาญ ปรางค์ประทานพร, Ruth E. Langley, William Allum, Matthew Nankivell, 袁靖华, David Cunningham, Heike I. Grabsch	2021	4
3	Performance of a HER2 testing algorithm specific for p53‐abnormal endometrial cancer Histopathology ·Lisa Vermij, Naveena Singh, Alicia León‐Castillo, Nanda Horeweg, Jan Oosting, Joseph W. Carlson, Vincent T.H.B.M. Smit, C. Blake Gilks, Tjalling Bosse	2021	14
4	Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study JNCI Journal of the National Cancer Institute ·Marthe M. de Jonge, Cor D. de Kroon, Donald T Hess, Jan Oosting, Joanne A. de Hullu, Marian J.E. Mourits, E. Gómez, Margreet G.E.M. Ausems, J. Margriet Collée, Klaartje van Engelen, Irma van de Beek, (unknown), Vincent T.H.B.M. Smit, Matti A. Rookus, Geertruida H. de Bock, Flora E. van Leeuwen, Tjalling Bosse, Olaf M. Dekkers, Christi J. van Asperen	2021	42
5	Genome‐wide characterization of 5‐hydoxymethylcytosine in melanoma reveals major differences with nevus Genes Chromosomes and Cancer ·Catarina Salgado, Jan Oosting, Bart Janssen, Rajiv Kumar, Nelleke A. Gruis, Remco van Doorn	2020	8
6	Genome-wide analysis of constitutional DNA methylation in familial melanoma Clinical Epigenetics ·Catarina Salgado, Nelleke A. Gruis, Bastiaan T. Heijmans, Jan Oosting, Remco van Doorn	2020	4
7	Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy Journal for ImmunoTherapy of Cancer ·Elham Beyranvand Nejad, Г.Г. ЕЛИСЕЕВ, Rohanah Rohanah, Marit J van Elsas, 汪志青, Jan Willem Kleinovink, Tetje C. van der Sluis, Suzanne van Duikeren, Amina F.A.S. Teunisse, Aart G. Jochemsen, Jan Oosting, Noel F.C.C. de Miranda, Thorbald van Hall, Ramon Arens, Sjoerd H. van der Burg	2020	18
8	Metabolic reprogramming related to whole-chromosome instability in models for Hürthle cell carcinoma Scientific Reports ·Ruben D. Addie, Sarantos Kostidis, Willem E. Corver, Jan Oosting, Sepideh Aminzadeh-Gohari, René G. Feichtinger, Barbara Kofler, Колупаева Екатерина Сергеевна, Martin Giera, Hans Morreau	2020	11
9	Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer BMC Cancer ·Tessa P. Sandberg, Norma Miranda Robayo, Jan Oosting, Rob A.�E.�M. Tollenaar, Cornelis F.M. Sier, Wilma E. Mesker	2019	98
10	Long-term Survival and Clinical Benefit from Adoptive T-cell Transfer in Stage IV Melanoma Patients Is Determined by a Four-Parameter Tumor Immune Signature Cancer Immunology Research ·Sara M. Melief, Valeria Visconti, Marten Visser, Merel van Diepen, Ellen Kapiteijn, Joost H. van den Berg, John B.A.G. Haanen, Vincent T.H.B.M. Smit, Jan Oosting, Sjoerd H. van der Burg, Els M.E. Verdegaal	2017	24
11	Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGFβ as Potential Targets American Journal Of Pathology ·Jolieke G. van Oosterwijk, Daniëlle Meijer, Josep Oriol Balagué Ferrer, Brendy E.W.M. van den Akker, Jan Oosting, Tibor Krenács, Piero Picci, Adrienne M. Flanagan, Bernadette Liegl‐Atzwanger, Andreas Leithner, Nick Athanasou, Søren Daugaard, Pancras C.W. Hogendoorn, Judith V.M.G. Bovée	2013	44
12	Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer BMC Cancer ·Arantza Fariña Sarasqueta, Giusi Irma Forte, Willem E. Corver, Noel F.C.C. de Miranda, Dina Ruano, Ronald van Eijk, Jan Oosting, Rob A.�E.�M. Tollenaar, Tom van Wezel, Hans Morreau	2013	39
13	Progression and Tumor Heterogeneity Analysis in Early Rectal Cancer Clinical Cancer Research ·Esther H. Lips, Ronald van Eijk, Eelco J. R. de Graaf, Pascal G. Doornebosch, Noel F.C.C. de Miranda, Jan Oosting, Tom M. Karsten, Paul H.C. Eilers, Rob A.�E.�M. Tollenaar, Tom van Wezel, Hans Morreau	2008	35
14	Genome-wide Allelic State Analysis on Flow-Sorted Tumor Fractions Provides an Accurate Measure of Chromosomal Aberrations Cancer Research ·Willem E. Corver, Anneke Middeldorp, Natalja T. ter Haar, Ekaterina S. Jordanova, Marjo van Puijenbroek, Ronald van Eijk, Cees J. Cornelisse, Gert Jan Fleuren, Hans Morreau, Jan Oosting, Tom van Wezel	2008	30
15	E2Fs mediate a fundamental cell‐cycle deregulation in high‐grade serous ovarian carcinomas The Journal of Pathology ·Tim De Meyer, Mark Roark, Ahmet Sahiner, Sofie Bekaert, Jan Oosting, Wim Van Criekinge, Manon van Engeland, R. M. Lepore	2008	39
16	Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis BMC Cancer ·Esther H. Lips, Ronald van Eijk, Dongjie Niu Cunkuan Bao, Jan Oosting, Noel F.C.C. de Miranda, Tom M. Karsten, Cornelis JH van de Velde, Paul H.C. Eilers, Rob A.�E.�M. Tollenaar, Tom van Wezel, Hans Morreau	2008	36
17	E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines British Journal of Cancer ·Marcel Lombaerts, Tom van Wezel, Katja Philippo, Jan Willem F Dierssen, Joshua Lea, Jan Oosting, Ronald van Eijk, Paul H.C. Eilers, Bob van de Water, Cees J. Cornelisse, W.J. Curran	2006	279
18	Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling The Journal of Pathology ·Liesbeth Hameetman, Negesso Gobena, Marcel Lombaerts, Jan Oosting, A. H. M. Taminiau, A.M. Cleton-Jansen, Judith V.M.G. Bovée, Pancras C.W. Hogendoorn	2006	61
19	Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis Tubercle and Lung Disease ·Clemens Richter, G. Nürnberg, A.B.M. Swai, R.M. Perenboom, D H Mwakyusa, Jan Oosting	1995	16
20	Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis British Journal of Cancer ·Sieger Leenstra, Peter De Meyer, Dirk Troost, Jan Oosting, A. Westerveld, L Wang, Charlotte Male	1994	48

About Jan Oosting

Jan Oosting is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Endocrine and Autonomic Systems and Reproductive Medicine, having authored 73 papers that have together received 2.5k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (18 papers), Sarcoma Diagnosis and Treatment (9 papers), Cancer Genomics and Diagnostics (8 papers), Cancer-related molecular mechanisms research (8 papers), Bone Tumor Diagnosis and Treatments (8 papers), Epigenetics and DNA Methylation (6 papers), Genomic variations and chromosomal abnormalities (6 papers) and Ovarian cancer diagnosis and treatment (6 papers). The work is most often cited by research in Cancer Research (673 citations), Oncology (767 citations), Pathology and Forensic Medicine (385 citations), Reproductive Medicine (141 citations) and Molecular Biology (1.1k citations). Jan Oosting has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Tom van Wezel, Ronald van Eijk, Harry A.J. Struijker-Boudier, Paul H.C. Eilers, Hans Morreau, Ben Janssen, Cees J. Cornelisse, Rob A.�E.�M. Tollenaar, Willem E. Corver and Marcel Lombaerts. Their work appears in journals such as The Journal of Pathology, BMC Cancer, Oncotarget, Genes Chromosomes and Cancer and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact